Dinaki Konstantina, Grigoriadis Nikolaos, Papadopoulos Constantinos, Vizirianakis Ioannis, Constantinidis Jannis, Triaridis Stefanos, Karkos Petros
ENT resident, 1st Academic ORL Department, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Postdoctoral researcher, Molecular Pharmacology and Pharmacogenomics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Maedica (Bucur). 2023 Dec;18(4):672-678. doi: 10.26574/maedica.2023.18.4.672.
Platelet-rich fibrin is a second-generation platelet concentrate. It is rich in platelets, cytokines, growth factors and leukocytes. Compared to platelet-rich plasma, it releases growth factors for a more extended amount of time. A literature review was conducted on the applications of platelet-rich fibrin in otolaryngology. Only articles written in English were further considered for the study; all others were excluded. Also, articles relating to oral and maxillofacial surgery were removed. Results: Twenty-five studies were deemed appropriate for inclusion in the present review. Based on the current data, platelet-rich fibrin appears to be a safe, healing-promoting material. It is a cost-effective, autologous material with enormous therapeutic application potential in the future. However, further clinical research is required before conclusive conclusions can be drawn about its usefulness.
富血小板纤维蛋白是第二代血小板浓缩物。它富含血小板、细胞因子、生长因子和白细胞。与富血小板血浆相比,它能在更长时间内释放生长因子。对富血小板纤维蛋白在耳鼻喉科的应用进行了文献综述。本研究仅进一步考虑用英文撰写的文章;所有其他文章均被排除。此外,与口腔颌面外科相关的文章也被剔除。结果:25项研究被认为适合纳入本综述。根据目前的数据,富血小板纤维蛋白似乎是一种安全的、促进愈合的材料。它是一种具有成本效益的自体材料,未来具有巨大的治疗应用潜力。然而,在就其效用得出确凿结论之前,还需要进一步的临床研究。